Dongchoul Kim, CEO What if culture monitoring within bioreactors wasn’t as convoluted and time-consuming?
Cubic K, a trailblazer in bioprocess optimization, is making this a reality. From its headquarters in Seoul, it collaborates with industry leaders to transform how researchers analyze cultures within bioreactors through cutting-edge technologies and a laser focus on client success. In essence, it achieves the real-time and nondestructive detection of target substances without needing manual, error-prone sampling.
“Our focus goes beyond monitoring bioreactors; we optimize production efficiency, enable real-time adjustments to analytical processes and enhance culture quality and yield, empowering clients to stay competitive and adapt swiftly in dynamic markets,” says Dongchoul Kim, CEO.
This forward-thinking vision drives Cubic K’s technological advancements, which combine innovative nanostructures, AI-driven analytics and real-time monitoring systems. Collectively, these tools enable unprecedented precision and efficiency in bioprocessing.
Unlike conventional methods that rely on labor-intensive sampling and delayed feedback, Cubic K’s real-time monitoring system streamlines bioprocessing with transformative advantages. Continuous monitoring eliminates the need for specialized personnel and repetitive tasks. At the same time, Cubic K’s direct integration of spectrometers into bioreactors bypasses the shortcomings of chromatographic analysis, reducing material waste, minimizing contamination risks and simplifying operations. It also provides real-time feedback, enabling instant optimization that enhances process efficiency and yields.
Central to Cubic K’s success is its ability to transform complex bioprocess challenges into actionable solutions. Its Surface-enhanced Raman scattering (SERS) technology revolutionizes substance detection with delivering extraordinary sensitivity. Embedding nanostructures within probe electrodes amplifies the electromagnetic fields as the nanostructures create localized plasmonic hotspots, dramatically enhancing Raman signals.
This allows the detection of trace concentrations of target materials with unmatched precision. Above all, its customizable nanostructures—optimized in shape, arrangement and surface properties—are revolutionizing bioprocessing applications, from detecting dissolved gases to monitoring culture conditions in real-time.
Equally impressive are Cubic K’s advanced AI algorithms, which filter out irrelevant noise from complex media and detect subtle changes (bio-chemical, physical etc) with remarkable precision. These smart insights allow for proactive interventions, identifying potential issues such as substance depletion or by-product accumulation. By integrating AI-driven data with process controllers, Cubic K achieves automated bioprocessing that ensures consistent production outcomes, minimizes human error and maximizes operational efficiency.
Cubic K’s groundbreaking work has set new industry benchmarks. An excellent example is its real-time analysis of critical gases, such as dissolved carbon monoxide, which has unlocked new efficiencies in C1 gas refinery processes. These advancements, coupled with the unparalleled sensitivity of nanostructure-enhanced detection, enable clients to achieve scalability and precision previously thought unattainable.
In an increasingly competitive landscape, Cubic K’s edge is powered by integrating real-time monitoring with advanced spectrometers and customized metallic nanostructures that ensure high sensitivity and accuracy. Its tailored platforms, designed using CFD simulations and 3D modeling, mitigate noise and optimize performance for client-specific reactors.
Our focus goes beyond monitoring bioreactors; we optimize production efficiency, enable real-time adjustments to analytical processes and enhance culture quality and yield, empowering clients to stay competitive and adapt swiftly in dynamic markets
Cubic K’s dedication to innovation extends beyond its current offerings. Its expertise and forward-thinking approach enables clients to solve complex challenges within their bioreactors. Notably, it collaborated with CJ Group and Daesang Group to tackle key operational challenges, demonstrating the impact of its tailored solutions on real-world applications. The company developed customized platforms and probe guards tailored to their specific bioreactors. These innovations prevented bubble interference, maintained fluid circulation and protected structural integrity, ensuring accurate and stable signal measurements. The result? Greater precision and reliability that continues empowering clients to achieve their bioprocessing objectives.
Cubic K’s excellence in technology and innovation has not gone unnoticed. The company has been recognized with prestigious accolades, such as the CES 2025 Innovation Awards and the 2024 FIX Innovation Awards in Korea, underscoring its leadership in advancing groundbreaking solutions. These honors highlight Cubic K’s exceptional contributions to biotechnological advancements, reinforcing its position as an industry pioneer.
With a vision firmly rooted in empowering clients through transformative technology, Cubic K is more than just a company; it’s a partner with a clear vision to drive progress in the biotechnology industry. As the bioprocessing landscape evolves, Cubic K continues pushing boundaries and setting the stage for a future characterized by innovation, precision and excellence.
